Tom Fahey Selected Research

Antihypertensive Agents (Antihypertensives)

3/2010	Interventions used to improve control of blood pressure in patients with hypertension.
12/2005	Organisational factors in relation to control of blood pressure: an observational study.
11/2005	Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tom Fahey Research Topics

Disease

10	Cough 01/2017 - 12/2003
8	Drug-Related Side Effects and Adverse Reactions 01/2021 - 03/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 07/2008
6	Hypertension (High Blood Pressure) 10/2018 - 09/2004
4	Stroke (Strokes) 01/2021 - 09/2005
4	Neonatal Abstinence Syndrome 04/2013 - 12/2010
3	Infections 01/2020 - 02/2003
3	Chronic Disease (Chronic Diseases) 03/2018 - 01/2017
3	Bronchitis 01/2017 - 03/2014
3	Fever (Fevers) 07/2007 - 07/2002
2	Rheumatoid Arthritis 11/2021 - 02/2014
2	Frailty 01/2021 - 04/2017
2	Osteoporosis 01/2021 - 04/2015
2	Heart Failure 01/2020 - 05/2010
2	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2014
2	Lung Diseases (Lung Disease) 01/2017 - 03/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2017
2	Pharyngitis (Sore Throat) 03/2016 - 06/2011
2	Neoplasms (Cancer) 09/2015 - 10/2014
2	Appendicitis 04/2015 - 01/2013
2	Respiratory Sounds (Crackle) 05/2010 - 07/2002
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2009 - 06/2005
2	Atrial Fibrillation 09/2005 - 09/2004
1	Lymphocytosis 01/2023
1	Urinary Incontinence 10/2022
1	COVID-19 09/2022
1	Poisoning 10/2020
1	Tinea Pedis (Athlete's Foot) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Syncope (Fainting) 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 10/2018
1	Melanoma (Melanoma, Malignant) 01/2017
1	Infectious Mononucleosis (Glandular Fever) 12/2016
1	Hemorrhage 12/2016
1	Hematoma 08/2015
1	Cellulitis 06/2015
1	Infertility (Sterility) 03/2015
1	Disease Progression 02/2014
1	Arthritis (Polyarthritis) 02/2014
1	Osteoarthritis 11/2013
1	Gastroenteritis 10/2013
1	Weight Loss (Weight Reduction) 10/2013
1	Vomiting 10/2013

Drug/Important Bio-Agent (IBA)

14	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2002
7	Methadone (Dolophine)FDA LinkGeneric 01/2021 - 06/2003
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2005
3	Vitamin D FDA LinkGeneric 01/2021 - 04/2015
3	nasIBA 04/2013 - 12/2010
3	Antihypertensive Agents (Antihypertensives)IBA 03/2010 - 11/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 11/2021
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021 - 04/2017
2	CalciumIBA 01/2021 - 04/2015
2	LipidsIBA 01/2017 - 03/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 07/2008
2	Expectorants (Mucolytics)IBA 11/2014 - 08/2012
2	Histamine Antagonists (Antihistamines)IBA 11/2014 - 08/2012
2	ORALIT (ORS)IBA 07/2007 - 01/2004
1	AntigensIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2022
1	Antipsychotic Agents (Antipsychotics)IBA 10/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 10/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Denosumab FDA Link 01/2021
1	AnticoagulantsIBA 01/2021
1	Floxacillin (Flucloxacillin)IBA 01/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	Penicillins (Penicillin)FDA Link 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020
1	Neprilysin (Neutral Endopeptidase)IBA 01/2020
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	1,2- dihexadecyl- sn- glycero- 3- phosphocholineIBA 10/2018
1	mirabegronIBA 10/2018
1	Prescription DrugsIBA 03/2018
1	N 30IBA 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 12/2016
1	Proton Pump InhibitorsIBA 12/2016
1	antineoplaston A10 (A 10)IBA 06/2016
1	Oral ContraceptivesIBA 03/2015
1	Progestins (Progestagens)IBA 03/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2014
1	Glucosamine (Dona)IBA 11/2013
1	EnzymesIBA 10/2013
1	LactaseIBA 10/2013
1	Lactose FDA LinkGeneric 10/2013

Therapy/Procedure

9	Therapeutics 01/2017 - 09/2005
7	Inappropriate Prescribing 01/2021 - 03/2013
7	Cardiopulmonary Resuscitation (CPR) 01/2017 - 06/2011
3	Polypharmacy 09/2022 - 01/2017
2	Aftercare (After-Treatment) 10/2020 - 09/2015
2	Ambulatory Care (Outpatient Care) 01/2017 - 02/2009
2	Secondary Prevention 03/2010 - 09/2004
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2021
1	Patient Transfer (Patient Dumping) 01/2018
1	Activities of Daily Living (ADL) 01/2017
1	Craniotomy 08/2015